These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 12063006)

  • 1. Optimizing radiation treatment plans for lung cancer using lung perfusion information.
    Seppenwoolde Y; Engelsman M; De Jaeger K; Muller SH; Baas P; McShan DL; Fraass BA; Kessler ML; Belderbos JS; Boersma LJ; Lebesque JV
    Radiother Oncol; 2002 May; 63(2):165-77. PubMed ID: 12063006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ga-68 MAA Perfusion 4D-PET/CT Scanning Allows for Functional Lung Avoidance Using Conformal Radiation Therapy Planning.
    Siva S; Devereux T; Ball DL; MacManus MP; Hardcastle N; Kron T; Bressel M; Foroudi F; Plumridge N; Steinfort D; Shaw M; Callahan J; Hicks RJ; Hofman MS
    Technol Cancer Res Treat; 2016 Feb; 15(1):114-21. PubMed ID: 25575575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A potential to reduce pulmonary toxicity: the use of perfusion SPECT with IMRT for functional lung avoidance in radiotherapy of non-small cell lung cancer.
    Lavrenkov K; Christian JA; Partridge M; Niotsikou E; Cook G; Parker M; Bedford JL; Brada M
    Radiother Oncol; 2007 May; 83(2):156-62. PubMed ID: 17493699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary function following high-dose radiotherapy of non-small-cell lung cancer.
    De Jaeger K; Seppenwoolde Y; Boersma LJ; Muller SH; Baas P; Belderbos JS; Lebesque JV
    Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1331-40. PubMed ID: 12654445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of intensity-modulated radiation therapy as a boost treatment on the lung-dose distributions for non-small-cell lung cancer.
    Choi Y; Kim JK; Lee HS; Hur WJ; Chai GY; Kang KM
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):683-9. PubMed ID: 15927412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single photon emission computed tomography (SPECT) or positron emission tomography (PET) imaging for radiotherapy planning in patients with lung cancer: a meta-analysis.
    Lee SJ; Park HJ
    Sci Rep; 2020 Sep; 10(1):14864. PubMed ID: 32913277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intensity modulated radiotherapy of non-small-cell lung cancer incorporating SPECT ventilation imaging.
    Munawar I; Yaremko BP; Craig J; Oliver M; Gaede S; Rodrigues G; Yu E; Reid RH; Leung E; Urbain JL; Chen J; Wong E
    Med Phys; 2010 Apr; 37(4):1863-72. PubMed ID: 20443508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimization of beam weights in conformal radiotherapy planning of stage III non-small cell lung cancer: effects on therapeutic ratio.
    De Gersem WR; Derycke S; De Wagter C; De Neve WC
    Int J Radiat Oncol Biol Phys; 2000 Apr; 47(1):255-60. PubMed ID: 10758332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dosimetric comparison of flattened and unflattened beams for stereotactic ablative radiotherapy of stage I non-small cell lung cancer.
    Hrbacek J; Lang S; Graydon SN; Klöck S; Riesterer O
    Med Phys; 2014 Mar; 41(3):031709. PubMed ID: 24593713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperpolarized
    Rankine LJ; Wang Z; Kelsey CR; Bier E; Driehuys B; Marks LB; Das SK
    Int J Radiat Oncol Biol Phys; 2021 Nov; 111(4):1044-1057. PubMed ID: 34265395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preserving functional lung using perfusion imaging and intensity-modulated radiation therapy for advanced-stage non-small cell lung cancer.
    Shioyama Y; Jang SY; Liu HH; Guerrero T; Wang X; Gayed IW; Erwin WD; Liao Z; Chang JY; Jeter M; Yaremko BP; Borghero YO; Cox JD; Komaki R; Mohan R
    Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1349-58. PubMed ID: 17446001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct incorporation of patient-specific efficacy and toxicity estimates in radiation therapy plan optimization.
    Polan DF; Epelman MA; Wu VW; Sun Y; Varsta M; Owen DR; Jarema D; Matrosic CK; Jolly S; Schonewolf CA; Schipper MJ; Matuszak MM
    Med Phys; 2022 Oct; 49(10):6279-6292. PubMed ID: 35994026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional lung avoidance and response-adaptive escalation (FLARE) RT: Multimodality plan dosimetry of a precision radiation oncology strategy.
    Lee E; Zeng J; Miyaoka RS; Saini J; Kinahan PE; Sandison GA; Wong T; Vesselle HJ; Rengan R; Bowen SR
    Med Phys; 2017 Jul; 44(7):3418-3429. PubMed ID: 28453861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased therapeutic ratio by 18FDG-PET CT planning in patients with clinical CT stage N2-N3M0 non-small-cell lung cancer: a modeling study.
    van Der Wel A; Nijsten S; Hochstenbag M; Lamers R; Boersma L; Wanders R; Lutgens L; Zimny M; Bentzen SM; Wouters B; Lambin P; De Ruysscher D
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):649-55. PubMed ID: 15708242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dosimetric Comparison of Real-Time MRI-Guided Tri-Cobalt-60 Versus Linear Accelerator-Based Stereotactic Body Radiation Therapy Lung Cancer Plans.
    Wojcieszynski AP; Hill PM; Rosenberg SA; Hullett CR; Labby ZE; Paliwal B; Geurts MW; Bayliss RA; Bayouth JE; Harari PM; Bassetti MF; Baschnagel AM
    Technol Cancer Res Treat; 2017 Jun; 16(3):366-372. PubMed ID: 28168936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incorporating quantitative single photon emission computed tomography into radiation therapy treatment planning for lung cancer: impact of attenuation and scatter correction on the single photon emission computed tomography-weighted mean dose and functional lung segmentation.
    Yin L; Shcherbinin S; Celler A; Thompson A; Fua TF; Liu M; Duzenli C; Gill B; Sheehan F; Powe J; Worsley D; Marks L; Moiseenko V
    Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):587-94. PubMed ID: 20452138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of inverse-planned three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for non-small-cell lung cancer.
    Christian JA; Bedford JL; Webb S; Brada M
    Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):735-41. PubMed ID: 17187941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Late-Course Adaptive Adjustment Based on Metabolic Tumor Volume Changes during Radiotherapy May Reduce Radiation Toxicity in Patients with Non-Small Cell Lung Cancer.
    Xiao L; Liu N; Zhang G; Zhang H; Gao S; Fu Z; Wang S; Yu Q; Yu J; Yuan S
    PLoS One; 2017; 12(1):e0170901. PubMed ID: 28125698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential for reduced toxicity and dose escalation in the treatment of inoperable non-small-cell lung cancer: a comparison of intensity-modulated radiation therapy (IMRT), 3D conformal radiation, and elective nodal irradiation.
    Grills IS; Yan D; Martinez AA; Vicini FA; Wong JW; Kestin LL
    Int J Radiat Oncol Biol Phys; 2003 Nov; 57(3):875-90. PubMed ID: 14529795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility of sparing lung and other thoracic structures with intensity-modulated radiotherapy for non-small-cell lung cancer.
    Liu HH; Wang X; Dong L; Wu Q; Liao Z; Stevens CW; Guerrero TM; Komaki R; Cox JD; Mohan R
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1268-79. PubMed ID: 15001272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.